Startups
Mnemo Therapeutics

Mnemo Therapeutics

https://mnemo-tx.com

Biotechnology firm focused on life science advancements.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 65

Locations

Company Size

  • 101 - 251

Last Stage Round

Insights

Mnemo Therapeutics, based in Paris, presents significant potential as a biotechnology firm focused on life sciences advancements. Their B2B model positions them well for collaborations within the healthcare industry. Backed by Sofinnova Partners, Mnemo has strong financial support. Their emphasis on advancing biotechnology offers a competitive edge, although reliance on existing medical technologies might slow innovation. However, their specialized focus allows them to target niche markets within the biotech sector, potentially leading to substantial growth opportunities despite the innovation challenges.

Total Funding
$89.6M

Investors

Full Company Profile